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IN a comparison between the results of the chemical analysis of 214 cyst fluids
associated with tumours of the brain and the histological findings in the same
patients, Szliwowski and Cumings (1961) include the determination of lactate
dehydrogenase (LDH) in the fluid from twenty-three astrocytomas, and four
secondary carcinomas. Glucose phosphate isomerase (GPI), (phosphohexose
isomerase, phosphoglucose isomerase) was also estimated in ten of the astro-
cytomas and one of the secondary tumours. The average enzyme content was
considerably higher for those fluids coming from secondary carcinomas though the
numbers were small. If this finding were confirmed and were reflected in an
increased enzyme content of plasma and cerebrospinal fluid we felt it might be of
use in differential diagnosis. We therefore set out to extend the observations
and make simultaneous determinations of enzyme activity in the cerebrospinal
fluid and/or cyst fluid and plasma in both types of tumour.
MATERIAL AND METHODS
Cyst fluid was removed by aspiration at open operation or burr-hole biopsy
or ventriculography. When a fluid was obtained from a patient the surgeon
concerned took a heparinised blood specimen as soon as conveniently possible
after aspirating the cyst. These specimens were sent without delay to the
laboratory where plasma was separated, frozen and stored at -15° C. Fluid
from pre-operative diagnostic ventriculography was centrifuged to remove cells
before storage. In some cases a blood specimen that had been taken for routine
purposes earlier in the day was used and in a few where it was omitted at the time
the cyst was aspirated a specimen taken later that day was used. On three occa-
sions plasma obtained both before and immediately after operation showed no
change in enzyme content.
Twenty-one cases with a glioma and sixteen with a cerebral secondary carci-
noma were investigated. The specimens obtained from these patients and the
histological diagnosis from the craniotomy or biopsy specimens are given in
Tables VII and VIII.
Twenty plasma specimens were obtained from members of the medical or
scientific staff to serve as controls. Normal ventricular CSF proved difficult toMONAMY BUCKELL AND MAY C. ROBERTSON
obtain since the employment of ultrasound and radioactive scanning techniques
in this department seems to have reduced the number ofventriculograms with no
abnormality demonstrated. Fluid from eight cases with a normal protein and
white cell content was analysed.
Lactate dehydrogenase was estimated colorimetrically (King, 1959). Glucose
phosphate isomerase was determined by Bodansky's (1954) method, and alkaline
and acid phosphatase according to King and Wooton (1956).
RESULTS
All results are expressed as International Units (i.u.) i.e. as micromols of
substrate transformed per minute per litre at 370 C. (King and Campbell, 1961).
Enzyme names used are those recommended in the Report of the Commission on
Enzymes of the International Union of Biochemistry (1961). Table I gives the
relation of international units to conventional units and all figures quoted have
been converted to international units.
TABLE I.-Relation of Conventional Enzyme Units to International Units
1 unit LDH, King (1959) 0 66 i.u.
1 unit LDH, Wroblewski and LaDue (1955) 0-5 i.u.
1 unit GPI, Bodansky (1954) 4-63 i.u.
1 unit GPI, Bruns, Jacob and Weverinck (1956) 16-6 i.u.
1 unit alk. phos., King and Wooton (1956) 7-1 i.u.
1 unit acid phos., King and Wooton (1956) 1- 8 i.u.
(A) Controls
Table II gives the enzyme concentrations found in the twenty control plasmas.
The phosphatases lie within the usually accepted limits of normal and the LDH
figures agree with those reported by King (1959) using the same method. Normal
values for plasma glucose phosphate isomerase are less well known and tend to
vary with the method used and the laboratory concerined. It is therefore felt
worthwhile to include here Table III which summarises the normal values reported
in the literature.
TABLE II.-Enzyme Activities in Normal Plasrma, Employing the
Methods used in this Investigation (International Units)
Number of
Enzyrne specimens AMean ± S.D. Range
LDH 20 187 ± 25 . 150-947
GPI . 20 36±10 20-55
Alk.phos.. 20 52±16 25-90
Acid phos. . 18 4- 5±1- 6 .2 5-9 3
We can find no reports ofthe LDH or GPI activity ofveintricular cerebrospinal
fluid. Ventricular fluid was examined as it is more often available than lumbar
in this type of case where raised intracranial pressure is frequently present, contra-
indicating lumbar puncture. Table IV gives the details of our eight control
ventricular CSF's and Tables V and VI give results from the literature for LDH
and GPI respectively in lumbar CSF.
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TABLE III.-Reported Normal Valuesfor Glucose Phosphate
Isomerase in Plasma (converted to International Units)
Author
Bodansky (1954)
Bruns, Jacob and Weverinck (1956)
Israels and Delory (1958)
White (1958)
Cattaneo, Prinotti, Rigazio (1960)
Gronvall (1961)
Joplin and Jegatheesan (1962)
Werners (1962)
Horrocks, Ward and King (1963)
Griffith and Beck (1963)
Number of
samples Method
87 . Bodansky
. Brms
20 . Bodansky
27 . Bodansky
20 . Bodansky
54 . Bodansky
34 . Bodansky
15 . " Optic System "
with NADP
100 . Horrocks et al.
33 . Bodansky
Range Mean S.D.
. 37-185 . 97 . 32
*- . 73
. 18-185 . 82 . 40
. 23-153 . 81 . 29
. 14-65 . 39 . 14
. 10-55 . 39. 9
. 28-93 . 56 16
. 18-59 . 41 . -
. 13-78 . 46
. 50-139 . 92
16
2a
NADP-Nicotinamide Adenine Dinucleotide Phosphate (formerly TPN).
TABLE IV.-Lactate Dehydrogenase, Glucose Phosphate Isomnerase, Acid and
Alkaline Phosphatase in Control Ventricular Cerebrospinal Fluid (in Inter-
national Units)
Diagnosis
Post-meningitic arachnoiditis
Cerebro-vascular disease
Cerebro-tendinous xanthomatosis
Basilar artery insufficiency
Cerebral atrophy
Cerebrovascular disease
NAD
Septicaemia
RBC
<10
150
<10
<10
10
20
<10
180
Protein
(mg. per
WBC 100 ml.)
<1 10
1 20
<1 15
2 15
<1 10
<1 15
<1 15
1 15
TABLE V.-Reported Normal Valuesfor Lactate Dehydrogenase in
Cerebrospinal Fluid (converted to International Units)
Author
Bruns, Jacob and Weverinck (1956)
Fleisher, Watkin and Goldstein (1957)
Wroblewski, Decker and Wroblewski (1957)
Jakoby and Jakoby (1958)
Green, Oldewurtel, O'Doherty and Forster (1958)
King, J. (1959)
Henry, Chiamou, Golub and Berkman (1960) .
Number
of
samples
14
30
30
20
30
16
Method
Oxidation of NADH2
Oxidation of NADH2
Oxidation of NADH2
Oxidation of NADH2
Oxidation of NADH2
Colorimetric
Oxidation of NADH2
Range
11-28
4-20
5-14
13-36
7-30
Mean
18
24
15
11
25
17
NADH2- Dihydro-nicotinamide Adenine Dinucleolide (formerly DPNH).
TABLE VI.-Reported Normal Valuesfor Glucose Phosphate Isomerase
in Cerebrospinal Fluid (converted to International Units)
Number
of
Author
Bruns, Jacob and Weverinck (1956)
Thompson, Hirschberg, Osnow and Gellhorn (1959).
Horrocks, Ward and King (1963) .
Hulanicka, Arend and Orlowski (1963) .
samples Method Range Mean
28 Bruns 2 - 5-38 15
- Bodansky 0-13-5 5-9
Horrocks 0- 3-6- 2
30 Orlowski 0-10-5
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Case
number
51
52
53
54
55
56
57
58
Age
48
68
66
63
60
68
64
58
LDH
16-7
0
13-3
15-3
0
20
3 3
8
GPI
2
18-6
5
10
3.3
3-3
24
2-7
Alk.
phos.
0
0
2-1
0 5*6
0
0
Acid
phos.
0
0
0 7
0 5
0 3
0
0MONAMY BUCKELL AND MAY C. ROBERTSON
(B) Patients
Tables VII and VIII give the lactate dehydrogenase, glucose phosphate iso-
merase, alkaline and acid phosphatase in plasma, ventricular CSF and cyst fluid
from cases of glioma and cerebral secondary carcinoma respectively.
Lactate dehydrogenase
The mean plasma LDH was 187 i.u. for the twenty control samples, 235 for
the twenty-one glioma patients and 219 for fourteen cases with cerebral secondary
carcinoma. Ineight of the gliomas and four of the secondaries the plasma LDH
was above the upper limit of the controls. LDH activity was present in measur-
able amounts in six ofeight control specimens ofventricular CSF and ranged from
0-20 i.u. Reported values in lumbar CSF (Table V) range from 4-36 units.
LDH was found in all but one of nine ventricular CSF specimens from glioma
patients; these eight specimens all lay above the mean for the controls and five
of the eight were above the upper control limit. A raised ventricular CSF LDH
was less common in the patients with secondary carcinoma, only one of the eight
being above normal. Mean values for ventricular CSF were: controls 9-6 i.u.,
cerebral secondary carcinoma 9-4 i.u., glioma group 28 i.u. High LDH activity
was found in the cyst fluid from both groups of cases. The mean LDH in eight
specimens from cystic secondaries was 3076 i.u. with a range of 840-10,000 i.u.
Table IX gives the mean LDH activity of cyst fluids in relation to the Kernohan
TABLE IX.-Mean Lactate Dehydrogenase Activity of Cerebral Cyst Fluids in
Relation to Histological Degree of Malignancy
Number of
Type of tumour cases Mean Range
Glioma grade 1 . . . 1 . 267
grade 2 . . 5 . 475 . 216-714
grade 3 . . . 11 . 3,030 . 500-6,760
grade 4 . . . 4 . 4,107 . 2,100-5,500
Secondary carcinoma . . 10 . 3,608 . 840-10,000
histological grade, this table includes all the cyst fluids from Tables VII and VIII
together with the results of a further 7 cases where no plasma or CSF specimen
is available. Except for two grade 2 tumours, all the cyst fluid LDH activities
fell above the corresponding plasma level, where this was done.
Glucose phosphate isomerase
In the twenty control specimens the plasma GPI ranged from 20-55 i.u. with a
mean of 36 i.u. This is slightly lower, and with a narrower range than most ofthe
series reported in the literature where the mean values are variously given as
from 39-97 i.u. (Table III). Mean plasma GPI's were 122 i.u. forthegliomagroup
range 50-260, and 126 i.u. for cerebral secondaries, range 45-242. In ventricular
fluids the GPI ranged from 4-24 units, with a mean of 8-6 i.u. As with LDH the
glioma group again had a higher average ventricular fluid enzyme activity than
that found for secondary carcinoma; inthe glioma group the mean GPI fornine
ventricular CSF's was 40 i.u. (range 2-76); the five samples with a raised LDH
also had a raised GPI. Two of eight ventricular CSF specimens from patients
with cerebral secondary carcinoma were above the upper limit of the control GPI
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activities, one ofthese also had a raised LDH content and the highest plasma LDH
ofthe group. The mean GPI activity offluids from cystic secondaries was higher
(4182) than that ofthe glioma group as awhole (1522) but only two cases are above
the upper limit ofthe gliomas and one fell into the range ofthe grade 2 gliomas.
Phosphatases
Plasma alkaline phosphatase was raised in three oftwenty-one cases ofglioma
and in one of fourteen patients with cerebral secondary carcinoma. No patient
in the secondary group and only one with a glioma had a raised plasma acid
phosphatase. Phosphatase activity was only occasionally found in the ventricular
CSF.
Alkaline phosphatase in cyst fluids ranged from 10-66 i.u. for the gliomas
(1.4-9.3 K.A. units) and from 17-44 i.u. for the fluids from secondary carcinoma.
The range of results found for grade 3 gliomas includes thefigures found for both
grade 2 and 4 specimens. Acidphosphatase in cystfluids rangedfrom 2*2-24X1 i.u.
for gliomas and 2X3-42-0 i.u. for carcinomas; again there was almost complete
overlapping of results from the different histological grades, but the number of
cases in each group having a cyst fluid acid phosphatase higher than their corres-
ponding plasma level increased with increasing degree of malignancy.
DISCUSSION
None of the findings reported above provides the basis of an absolute
biochemical distinction between a primary cerebral tumour and a metastasis.
The presence of malignant tissue at more than one site did not produce more
plasma activity ofthe enzymes examined, indeed the reverse was the case. Joplin
and Jegatheesan (1962) found serum isomerase to be elevated in 85 % of cases of
breast carcinomatosis and to show a good correlation with clinical status after
pituitary destruction. Griffith and Beck (1963) found elevated GPI levels in
80 % of patients with progressive metastatic breast carcinoma and reported that
alterations in enzyme activity paralleled regression or progression of the growth
and antedated other evidence by days or weeks. In our patients a raised plasma
GPI was found in 79 % ofcases with cerebral metastases, from a variety ofprimary
sites (see Table VIII) but was also found in an even greater proportion (95 %) of
glioma patients, noneofwhomwerealsosufferingfromrecentmyocardial infarction,
hepatic disease or inflammatory processes. The average increase of plasma GPI
activity was very similar in the two groups and was about three and a half times
the control value.
The total LDH activity of plasma was less often increased, and in neither
group were the increases that occurred as great as those with plasma GPl; 29%
ofpatients with cerebral secondaries and 38 % ofthe glioma group had an increased
plasma total LDH. None of the enzymes studied in plasma showed any correla-
tion with the histological grade ofthe tumour, the presence ofa cyst in the tumour
or the corresponding enzyme activity in the cyst fluid. The original hope that
Szliwowski and Cumings' (1961) findings of high cyst fluid activities might be
reflected in plasma was therefore not fulfilled.
Chemical grading of cyst fluids on the basis of their protein, cholesterol and
alkaline phosphatase content was proposed by Szliwowski and Cumings (1961)
in our experience a slightly better agreement with the histological estimation of
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the degree ofmalignancy is obtained from the LDH content ofthe fluid. As will be
seen from Table IX, there is considerable overlap between the groups, but histo-
logical grading is in itself a partly subjective procedure and is dependant on the
sampled area being representative of the tumour as a whole. Whether the fluid
that accumulates in a cyst is a fair reflection of the degree of cellular activity in
the tumour at the time of sampling is not yet decided. That it does bear a fairly
close relation to the histological appearance is shown by these results, as well as
by the earlier work of Szliwowski and Cumings.
In estimating the total LDH ofa fluid, care must be taken to avoid contamina-
tion with enzyme derived from red blood cells. If bleeding occurs during the
sampling the supernatant fluid must be separated as soon as possible and cell--
containing specimens must not be stored or frozen. Spontaneous haemorrhage
into a benign cystic tumour will produce a false appearance of malignancy in the
fluid so that haemorrhagic specimens are unsuitable for examination by the total
LDH method. As the LDH ofred cells is mainly in the fast moving or heat stable
isoenzymesandtheincrease ofenzyme inmalignanttissue occursintheslowmoving
or heatlabile fractions (RichterichandBurger, 1963) a separation couldbe obtained
on these lines. Isoenzyme determinations can also show an increase in one
fraction not reflected in the total figure because ofa concomitant decrease inoneof
the other fractions. This approach is now being pursued in this laboratory.
SUMMARY
1. Lactate dehydrogenase content of fluid from cystic cerebral tumours was.
found to run parallel with the degree ofmalignancy as determined by histological
grading. This change was not reflected in either the corresponding plasma or-
ventricular CSF.
2. Glucose phosphate isomerase, alkaline or acid phosphatase in cyst fluids.
did not follow the histological grade as closely as did lactate dehydrogenase.
3. Increased plasma glucose phosphate isomerase was found in 95 % ofpatients.
with gliomas and in 79 % of cases of cerebral secondary carcinoma.
4. Increased plasma lactate dehydrogenase was found in 38 % of patients with-
gliomas and in 29 % of cases of cerebral secondary carcinoma.
5. Lactate dehydrogenase and glucose phosphate isomerase activities in
control specimens of ventricular CSF are reported.
6. Enzyme increases were more common in the ventricular CSF of patients-
with gliomas than in those with cerebral secondary carcinoma.
This work was carried out with financial support of the British Empire Cancer
Campaign for Research and the Medical Research Council.
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